FEATURED: Katherine Kim on Sector Cash Inflow

You are Watching: Maturing Biotech Sector Likely to see Large Cash Inflow after Genentech & ImClone Deals, says Katherine Kim [BoA] The $60+Bn generated from large cap acquisitions are likely to be reinvested in biotech, specifically in 4 tranches of the sector. Katherine Kim reviews gives us the rationales behind this thinking. She also expects increased M&A activity in the years to come. This interview was conducted at the NASDAQ Marketsite, on August 25th, 2008, in New York City ...



http://www.youtube.com/watch?v=TggB4oWqeqw&hl=en

Related : shacklee drug attorney health insurance commercial bank House Insurance